Share Capital (Details) - USD ($) |
3 Months Ended | 6 Months Ended | ||||||
|---|---|---|---|---|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2025 |
Jun. 30, 2024 |
Mar. 31, 2025 |
Dec. 31, 2024 |
Mar. 31, 2024 |
Dec. 31, 2023 |
|
| Share Capital [Line Items] | ||||||||
| Common stock shares outstanding (in Shares) | 4,901,677 | 4,901,677 | ||||||
| Percentage of common shares issued and outstanding | 10.00% | |||||||
| Share-based compensation | $ 21,476 | |||||||
| Share based compensation options vested | $ 387,476 | $ 160,865 | ||||||
| Unvested stock options | 235,843 | $ 235,843 | ||||||
| Weighted average period for recognizing expense | 2 years 9 months | |||||||
| Grant date fair value of options granted (in Dollars per share) | $ 1.56 | |||||||
| Option granted (in Shares) | ||||||||
| Intrinsic value of outstanding options | $ 59,900 | $ 59,900 | ||||||
| Warrants issued (in Shares) | 1,077,586 | |||||||
| Exercise price per share (in Dollars per share) | $ 4 | |||||||
| Warrant balance (in Shares) | 7,030 | 7,030 | ||||||
| Common Stock [Member] | ||||||||
| Share Capital [Line Items] | ||||||||
| Common stock shares outstanding (in Shares) | 4,901,677 | 2,506,015 | 4,901,677 | 2,506,015 | 4,901,677 | 4,901,677 | 2,506,015 | 2,506,015 |
| X | ||||||||||
- Definition Amount of expense for award under share-based payment arrangement. Excludes amount capitalized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of warrants or rights outstanding. No definition available.
|
| X | ||||||||||
- Definition Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of cost to be recognized for option under share-based payment arrangement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Percentage of common shares issued and outstanding. No definition available.
|
| X | ||||||||||
- Definition Weighted average period for recognizing remaining expense. No definition available.
|
| X | ||||||||||
- Details
|